Lyka Labs Limited (LYKALABS) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.135x

Based on the latest financial reports, Lyka Labs Limited (LYKALABS) has a cash flow conversion efficiency ratio of 0.135x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs136.84 Million ≈ $1.48 Million USD) by net assets (Rs1.01 Billion ≈ $10.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see LYKALABS market cap overview for the company's overall valuation and market capitalisation.

Lyka Labs Limited - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Lyka Labs Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Lyka Labs Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lyka Labs Limited ranked by their cash flow conversion efficiency. Explore LYKALABS cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Alset Ehome International Inc
NASDAQ:AEI
-0.063x
Sunson Textile Manufacturer
JK:SSTM
0.006x
VivoPower International PLC
NASDAQ:VVPR
0.221x
Ruanyun Edai Technology Inc. Ordinary shares
NASDAQ:RYET
-0.058x
Prevision Sanitaria Nacional Gestion SOCIMI S.A.
MC:YPSN
N/A
EON Resources Inc.
NYSE MKT:EONR
-0.127x
Candles Scandinavia AB Series B
ST:CANDLE-B
-0.085x
Atlas Engineered Products Ltd
V:AEP
0.050x

Annual Cash Flow Conversion Efficiency for Lyka Labs Limited (2005–2025)

The table below shows the annual cash flow conversion efficiency of Lyka Labs Limited from 2005 to 2025. View latest Lyka Labs Limited stock price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs1.04 Billion
≈ $11.20 Million
Rs18.99 Million
≈ $205.41K
0.018x -29.41%
2024-03-31 Rs682.65 Million
≈ $7.38 Million
Rs17.73 Million
≈ $191.78K
0.026x -86.75%
2023-03-31 Rs456.71 Million
≈ $4.94 Million
Rs89.53 Million
≈ $968.19K
0.196x -96.66%
2022-03-31 Rs134.91 Million
≈ $1.46 Million
Rs792.46 Million
≈ $8.57 Million
5.874x +1772.76%
2021-03-31 Rs-250.93 Million
≈ $-2.71 Million
Rs88.11 Million
≈ $952.93K
-0.351x +0.32%
2020-03-31 Rs-151.11 Million
≈ $-1.63 Million
Rs53.23 Million
≈ $575.71K
-0.352x -160.45%
2019-03-31 Rs457.59 Million
≈ $4.95 Million
Rs266.66 Million
≈ $2.88 Million
0.583x +211.82%
2018-03-31 Rs582.36 Million
≈ $6.30 Million
Rs108.83 Million
≈ $1.18 Million
0.187x -74.93%
2017-03-31 Rs421.01 Million
≈ $4.55 Million
Rs313.81 Million
≈ $3.39 Million
0.745x +1938.60%
2016-03-31 Rs491.54 Million
≈ $5.32 Million
Rs-19.93 Million
≈ $-215.50K
-0.041x -107.11%
2015-03-31 Rs465.71 Million
≈ $5.04 Million
Rs265.40 Million
≈ $2.87 Million
0.570x -64.17%
2014-03-31 Rs560.17 Million
≈ $6.06 Million
Rs890.99 Million
≈ $9.64 Million
1.591x +914.04%
2013-03-31 Rs697.62 Million
≈ $7.54 Million
Rs109.43 Million
≈ $1.18 Million
0.157x +154.43%
2012-03-31 Rs755.73 Million
≈ $8.17 Million
Rs-217.78 Million
≈ $-2.36 Million
-0.288x -380.89%
2010-03-31 Rs1.43 Billion
≈ $15.41 Million
Rs146.23 Million
≈ $1.58 Million
0.103x +129.68%
2008-03-31 Rs780.73 Million
≈ $8.44 Million
Rs-269.87 Million
≈ $-2.92 Million
-0.346x -33.00%
2007-03-31 Rs460.74 Million
≈ $4.98 Million
Rs-119.75 Million
≈ $-1.29 Million
-0.260x -136.00%
2005-03-31 Rs286.25 Million
≈ $3.10 Million
Rs206.68 Million
≈ $2.24 Million
0.722x --

About Lyka Labs Limited

NSE:LYKALABS India Biotechnology
Market Cap
$31.54 Million
Rs2.92 Billion INR
Market Cap Rank
#23690 Global
#1307 in India
Share Price
Rs81.71
Change (1 day)
+0.00%
52-Week Range
Rs44.95 - Rs99.79
All Time High
Rs254.30
About

Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-d… Read more